J. E. Landegent

897 total citations
23 papers, 709 citations indexed

About

J. E. Landegent is a scholar working on Hematology, Immunology and Molecular Biology. According to data from OpenAlex, J. E. Landegent has authored 23 papers receiving a total of 709 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Hematology, 10 papers in Immunology and 5 papers in Molecular Biology. Recurrent topics in J. E. Landegent's work include Acute Myeloid Leukemia Research (7 papers), Hematopoietic Stem Cell Transplantation (6 papers) and Chronic Myeloid Leukemia Treatments (5 papers). J. E. Landegent is often cited by papers focused on Acute Myeloid Leukemia Research (7 papers), Hematopoietic Stem Cell Transplantation (6 papers) and Chronic Myeloid Leukemia Treatments (5 papers). J. E. Landegent collaborates with scholars based in Netherlands, Germany and United Kingdom. J. E. Landegent's co-authors include R.W. Dirks, J.H. Frederik Falkenburg, Roel Willemze, Willem E. Fibbe, Hanneke C. Kluin‐Nelemans, Petra Kluck, Ellie G.A. Lurvink, Cornelis A.M. van Bergen, Willem M. Smit and Amon R. Wafelman and has published in prestigious journals such as Blood, The Journal of Immunology and British Journal of Haematology.

In The Last Decade

J. E. Landegent

22 papers receiving 687 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
J. E. Landegent Netherlands 12 305 297 224 183 170 23 709
Ulla Bergholz Germany 13 255 0.8× 157 0.5× 399 1.8× 191 1.0× 113 0.7× 16 685
Yanka Manolova Sweden 11 189 0.6× 126 0.4× 178 0.8× 128 0.7× 360 2.1× 27 826
M Eder Germany 13 184 0.6× 143 0.5× 299 1.3× 60 0.3× 110 0.6× 18 625
G. de Lange Netherlands 11 219 0.7× 275 0.9× 185 0.8× 100 0.5× 46 0.3× 32 569
M. Alcorn United Kingdom 14 420 1.4× 144 0.5× 131 0.6× 130 0.7× 195 1.1× 23 678
John E. Hopper United States 13 168 0.6× 344 1.2× 277 1.2× 60 0.3× 61 0.4× 24 730
AD Auerbach United States 9 328 1.1× 65 0.2× 730 3.3× 244 1.3× 174 1.0× 10 1.0k
Pierre Rollini Switzerland 16 69 0.2× 569 1.9× 285 1.3× 223 1.2× 63 0.4× 22 960
S Gisselbrecht France 12 201 0.7× 140 0.5× 228 1.0× 123 0.7× 70 0.4× 22 523
Joanne Martinis United States 8 125 0.4× 244 0.8× 260 1.2× 89 0.5× 105 0.6× 10 627

Countries citing papers authored by J. E. Landegent

Since Specialization
Citations

This map shows the geographic impact of J. E. Landegent's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J. E. Landegent with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J. E. Landegent more than expected).

Fields of papers citing papers by J. E. Landegent

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J. E. Landegent. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J. E. Landegent. The network helps show where J. E. Landegent may publish in the future.

Co-authorship network of co-authors of J. E. Landegent

This figure shows the co-authorship network connecting the top 25 collaborators of J. E. Landegent. A scholar is included among the top collaborators of J. E. Landegent based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J. E. Landegent. J. E. Landegent is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Falkenburg, J.H. Frederik, Amon R. Wafelman, Peter Joosten, et al.. (1999). Complete Remission of Accelerated Phase Chronic Myeloid Leukemia by Treatment With Leukemia-Reactive Cytotoxic T Lymphocytes. Blood. 94(4). 1201–1208. 13 indexed citations
2.
Soest, Ronald A van, et al.. (1998). Sublocalization of the breakpoints of a t(5;16) in myelodysplasia. Cancer Genetics and Cytogenetics. 100(1). 5–9. 1 indexed citations
3.
Melenhorst, J. Joseph, et al.. (1997). Analysis of T‐cell clonality in bone marrow of patients with acquired aplastic anaemia. British Journal of Haematology. 96(1). 85–91. 19 indexed citations
4.
Esendam, Bennie, et al.. (1997). The role of cytokines and hematopoietic growth factors in the autocrine/paracrine regulation of inducible hematopoiesis. Annals of Hematology. 75(1-2). 27–31. 20 indexed citations
5.
6.
Krieken, J. Han van, et al.. (1997). T cells selectively infiltrate bone marrow areas with residual haemopoiesis of patients with acquired aplastic anaemia. British Journal of Haematology. 99(3). 517–519. 24 indexed citations
7.
Hofstra, Robert M.W., Rein P. Stulp, Ying Wu, et al.. (1997). Absence of mutations in the RET gene in acute myeloid leukemia. Annals of Hematology. 75(3). 87–90. 12 indexed citations
8.
Willemze, Roel, Marian Stevens‐Kroef, Robby E. Kibbelaar, et al.. (1997). 71 Clonality of hematopoiesis in myelodysplasia. Leukemia Research. 21(1). S19–S19.
9.
Willemze, Roel, et al.. (1996). Haemopoietic growth factor tyrosine kinase receptor expression profiles in normal haemopoiesis. British Journal of Haematology. 94(2). 236–241. 9 indexed citations
10.
Jansen, Joop H., et al.. (1996). Detection of partial cDNA sequences differentially expressed in patients with myelodysplasia. Annals of Hematology. 72(4). 231–236. 3 indexed citations
11.
Melenhorst, J. Joseph, et al.. (1996). APLASTIC ANAEMIA PATIENTS WITH CLONAL X‐CHROMOSOME INACTIVATION PATTERN IN HAEMOPOIETIC CELLS EXHIBIT POLYCLONAL TCRγ AND IgH GENE REARRANGEMENTS. British Journal of Haematology. 93(2). 326–332. 4 indexed citations
12.
Esendam, Bennie, et al.. (1994). IL-4 down-regulates IL-2-, IL-3-, and GM-CSF-induced cytokine gene expression in peripheral blood monocytes. Annals of Hematology. 68(6). 293–298. 7 indexed citations
13.
Willemze, R., Willem E. Fibbe, JH Falkenburg, et al.. (1993). Biology and treatment of myelodysplastic syndromes — developments in the past decade. Annals of Hematology. 66(3). 107–115. 21 indexed citations
14.
Kluck, Petra, J. Wiegant, Anton K. Raap, et al.. (1993). Order of human hematopoietic growth factor and receptor genes on the long arm of chromosome 5, as determined by fluorescence in situ hybridization. Annals of Hematology. 66(1). 15–20. 6 indexed citations
15.
Wessels, J.W., W.E. Fibbe, J. E. Landegent, et al.. (1993). t(5;12)(q31;p12) A clinical entity with features of both myeloid leukemia and chronic myelomonocytic leukemia. Cancer Genetics and Cytogenetics. 65(1). 7–11. 50 indexed citations
16.
Schaafsma, M. Ronald, JH Falkenburg, N Duinkerken, et al.. (1993). Interleukin-9 stimulates the proliferation of enriched human erythroid progenitor cells: additive effect with GM-CSF. Annals of Hematology. 66(1). 45–49. 7 indexed citations
17.
Kamp, H van, J. E. Landegent, R. Willemze, Renée S. Jansen, & Willem E. Fibbe. (1991). (C11) Clonality of hematopoiesis in patients with aplastic anemia and myelodysplastic syndromes. Leukemia Research. 15. 7–7. 2 indexed citations
18.
Jansen, J, et al.. (1991). Interleukin 4 down-regulates the expression of CD14 and the production of interleukin 6 in acute myeloid leukemia cells.. PubMed. 10(6). 457–61. 7 indexed citations
19.
Landegent, J. E., et al.. (1987). Use of whole cosmid cloned genomic sequences for chromosomal localization by non-radioactive in situ hybridization. Human Genetics. 77(4). 366–370. 160 indexed citations
20.
Poels, Lambert G., et al.. (1984). Further evidence against random polyclonal antibody formation in mice with lupus-like graft-vs-host disease.. The Journal of Immunology. 132(4). 1814–1820. 39 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ulla Bergholz Breakdown of academic impact, for papers by Yanka Manolova Breakdown of academic impact, for papers by M Eder Breakdown of academic impact, for papers by G. de Lange Breakdown of academic impact, for papers by M. Alcorn Breakdown of academic impact, for papers by John E. Hopper Breakdown of academic impact, for papers by AD Auerbach Breakdown of academic impact, for papers by Pierre Rollini Breakdown of academic impact, for papers by S Gisselbrecht Breakdown of academic impact, for papers by Joanne Martinis
Rankless by CCL
2026